UKRI Chief Executive

03 February 2017

Commenting on the appointment of Sir Mark Walport as the first Chief Executive of UKRI, Acting Director of the Russell Group Dr Tim Bradshaw said:


Professor Sir Mark Walport is respected as an advocate for fundamental science and research. The appointment of someone of his stature and experience to this new role is welcome and we look forward to working closely with him over the coming months.

The UK has a highly efficient research ecosystem with the dual funding system delivering growth, jobs and innovation for the UK.  Our universities are world leaders in science and innovation and UKRI will have a key role in sustaining this position for the long-term future.


Policy area

Related case studies

Reducing blood transfusions to lower patient risk, reduce costs and save lives

More than half a million people in the UK receive a blood transfusion each year and demand is increasing. Our ageing population, and a stringent donor selection process, mean the supply of blood is limited. 40% fewer new donors came forward last year compared with a decade ago. Recognising these challenges, researchers at the University of Edinburgh have shown the benefits of reducing the use of blood transfusions in intensive care and surgery.

Read more >